Entheon Biomedical Corp.

    Entheon Biomedical Corp.

    CCSE:ENBI
    - -
    CAD
    - -
    - -
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    0.03
    0.04
    - -
    - -
    - -
    Basic EPS, GAAP
    - -
    -0.36
    -0.38
    -0.24
    -1.6
    -1.64
    -1.44
    -0.05
    -0.04
    -0.02
    -0.03
    Free Cash Flow per Basic Share
    -0.01
    -0.57
    -1.51
    -0.31
    -1.04
    -1.05
    -0.33
    -0.06
    -0.05
    -0.02
    -0.03
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    0.11
    0.64
    3.74
    2.35
    0.91
    1.07
    -0.38
    -0.23
    -0.11
    -0.02
    -0.03
    Tangible Book Value per Share
    0.11
    0.93
    4.31
    2.81
    1.36
    0.58
    0.1
    0.05
    0.02
    0.02
    0.04
    Basic Weighted Avg Shares
    - -
    - -
    - -
    1
    3
    5
    6
    6
    8
    13
    12
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    -1,898.18
    -124.96
    - -
    - -
    - -
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    - -
    - -
    - -
    - -
    -4
    -9
    -9
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    -4,492.23
    -119.85
    - -
    - -
    - -
    Working Capital
    - -
    - -
    1
    1
    4
    2
    1
    - -
    - -
    - -
    - -
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    - -
    - -
    2
    2
    4
    9
    1
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    -96.52
    -17.29
    -9.84
    -224.41
    -214.27
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    CAD

    •

    in mil. unless spec.
    Aug'24
    Nov'24
    May'25
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    9
    9
    14
    Market Capitalization
    2
    1
    1

    Working Capital

    CAD

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    CAD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    13.77%
    122.97%
    Free Cash Flow
    - -
    -11.88%
    -11.52%
    Net Income, GAAP
    - -
    2.02%
    1.92%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    -0.01
    -0.01
    -0.01
    - -
    -0.04
    2025
    -0.01
    - -
    - -
    - -
    -0.02
    2026
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CAD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business